Early Access Programs. The Parties shall discuss at the Steering Committee the appropriate mechanism for considering, approving, providing for supply of Licensed Product in respect of, and otherwise administering, any Early Access Programs [***].
Appears in 2 contracts
Sources: Exclusive License and Supply Agreement (Protalix BioTherapeutics, Inc.), Exclusive License and Supply Agreement (Protalix BioTherapeutics, Inc.)